Abstract
Genetic disorders are in the differential diagnosis when young children present with unexplained fractures or intracranial hemorrhage. For medical and legal reasons, it is imperative to make the correct diagnosis and provide clear, evidence-based explanations of how alternative diagnoses were ruled out. A genetics consultation in cases of suspected child physical abuse should synthesize the history of present illness, medical history, family history, physical examination, and radiologic and laboratory findings in consultation with other specialists. The medical geneticist highlights how these disorders truly present. When the natural history of a genetic disorder is understood, it becomes clear that genetic disorders are not mysterious or difficult to diagnose. As highlighted in this case-based review, mainstream medical practice allows for differentiation among the intracranial and skeletal manifestations of osteogenesis imperfecta, Menkes disease, glutaric acidemia type 1 and child physical abuse. This review also highlights how a genetic disorder, Ehlers–Danlos syndrome, can be misused in a courtroom. Finally, this review summarizes when genetic testing is appropriate in cases of suspected child physical abuse.
Similar content being viewed by others
References
Christian CW, Committee on Child Abuse and Neglect, American Academy of Pediatrics (2015) The evaluation of suspected child physical abuse. Pediatrics 135:e1337–e1354
Flaherty EG, Perez-Rossello JM, Levine MA et al (2014) Evaluating children with fractures for child physical abuse. Pediatrics 133:e477–e489
Servaes S, Brown SD, Choudhary AK et al (2016) The etiology and significance of fractures in infants and young children: a critical multidisciplinary review. Pediatr Radiol 46:591–600
Choudhary AK, Servaes S, Slovis TL et al (2018) Consensus statement on abusive head trauma in infants and young children. Pediatr Radiol 48:1048–1065
National Institutes of Health (2020) Osteogenesis imperfecta. Genetics home reference. NIH online database. https://ghr.nlm.nih.gov/condition/osteogenesis-imperfecta. Accessed 28 April 2020
Kang H, Aryal ACS, Marini JC (2017) Osteogenesis imperfecta: new genes reveal novel mechanisms in bone dysplasia. Transl Res 181:27–48
Steiner RD, Basel D (2005) COL1A1/2 osteogenesis imperfecta. GeneReviews. https://www.ncbi.nlm.nih.gov/books/NBK1295. Accessed 26 April 2020
Marlowe A, Pepin MG, Byers PH (2002) Testing for osteogenesis imperfecta in cases of suspected non-accidental injury. J Med Genet 39:382–386
Pepin MG, Byers PH (2015) What every clinical geneticist should know about testing for osteogenesis imperfecta in suspected child abuse cases. Am J Med Genet C Semin Med Genet 169:307–313
Byers PH, Krakow D, Nunes ME et al (2006) Genetic evaluation of suspected osteogenesis imperfecta (OI). Genet Med 8:383–388
Lim JY, Bhatia NS, Vasanwala RF et al (2019) A novel Ser40Trp variant in IFITM5 in a family with osteogenesis imperfecta and review of the literature. Clin Dysmorphol 28:120–125
Pierce MC, Kaczor K, Aldridge S et al (2010) Bruising characteristics discriminating physical child abuse from accidental trauma. Pediatrics 125:67–74
Zarante YA, Clingenppel R, Sellars E et al (2016) COL1A1 and COL1A2 sequencing results in cohort of patients undergoing evaluation for potential child abuse. Am J Med Genet A 170:1858–1862
Greeley CD, Donaruma-Kwoh M, Vettimattam M et al (2013) Fractures at diagnosis in infants and children with osteogenesis imperfecta. Pediatr Orthop 33:32–36
Tinkle B, Castori M, Berglund B et al (2017) Hypermobile Ehlers–Danlos syndrome (a.k.a. Ehlers–Danlos syndrome type III and Ehlers–Danlos syndrome hypermobility type): clinical description and natural history. Am J Med Genet C Semin Med Genet 175:48–69
Malfait F, Francomano C, Byers P et al (2017) The 2017 international classification of the Ehlers–Danlos syndromes. Am J Med Genet C Semin Med Genet 175:8–26
Malfait F, Wenstrup R, De Paepe A (2007) Classic Ehlers-Danlos syndrome. GeneReviews. https://www.ncbi.nlm.nih.gov/books/NBK1244. Accessed 28 April 2020
George M, Shur N, Perez-Rossello J (2020) Ehlers-Danlos syndrome: what the radiologist needs to know. Pediatr Radiol. https://doi.org/10.1007/s00247-020-04856-1
Rolfes M, Deyle D, King K et al (2019) Fracture incidence in Ehlers–Danlos syndrome — a population-based case-control study. Child Abuse Negl 91:95–101
Basalom S, Rauch F (2020) Bone disease in patients with Ehlers–Danlos syndromes. Curr Osteoporos Rep 18:95–102
Shur N (2019) A case of broken bones and systems: the threat of irresponsible testimony. Am J Med Genet A 179:429–434
Holick MF, Hossein-Nezhad A, Tabatabaei F (2017) Multiple fractures in infants who have Ehlers–Danlos/hypermobility syndrome and or vitamin D deficiency: a case series of 72 infants whose parents were accused of child abuse and neglect. Dermatoendocrinol 9:1
Schilling S, Wood J, Levine M et al (2011) Vitamin D status in abused and nonabused children younger than 2 years old with fractures. Pediatrics 127:835–841
Levy HP (2004) Hypermobile Ehlers–Danlos syndrome. GeneReviews. https://www.ncbi.nlm.nih.gov/books/NBK1279. Accessed 27 April 2020
Grudniewicz A, Moher D, Cobey KD et al (2019) Predatory journals: no definition, no defense. Nature 576:210–212
Leventhal J, Edwards G (1997) Flawed theories to explain child physical abuse: what are the medical–legal consequences? JAMA 318:1317–1318
Chadwick DL, Korss HF (1997) Irresponsible testimony by medical experts in cases involving the physical abuse and neglect of children. Child Maltreat 2:313–321
Strouse PJ (2016) Child abuse: we have problems. Pediatr Radiol 46:587–590
Shur N, Hinds T, Shalaby-Rana E et al (2019) Invited commentary: his life was lost but his heart still beats: in honor of children harmed by child abuse. Am J Med Genet A 179:2329–2332
Miller A, Narang S, Scribano P et al (2020) Ethical testimony in cases of suspected child maltreatment: the Ray E. Helfer Society guidelines. Acad Pediatr 20:742–745
Kaler SG (2003) ATP7A-related copper transport disorders. GeneReviews. https://www.ncbi.nlm.nih.gov/books/NBK1413. Accessed on 29 April 2020
Manara R, D’Agata L, Rocco MC et al (2017) Neuroimaging changes in Menkes disease, part 1. AJNR Am J Neuroradiol 38:1850–1857
Manara R, D’Agata L, Rocco MC et al (2017) Neuroimaging changes in Menkes disease, part 2. AJNR Am J Neuroradiol 38:1858–1865
Nassogne M, Sharrard M, Hertz-Pannier L et al (2002) Massive subdural haematomas in Menkes disease mimicking shaken baby syndrome. Childs Nerv Syst 18:729–731
Suvimol CH, Andrew D, Kaler S (2012) Cervical spine anomalies in Menkes disease: a radiologic finding potentially confused with child abuse. Pediatr Radiol 42:1301–1304
Cronin H, Fussell JN, Pride H, Bellino P (2012) Menkes syndrome presenting as possible child abuse. Cutis 90:170–172
Bacopoulou F, Henderson L, Philip SG (2006) Menkes disease mimicking non-accidental injury. Arch Dis Child 91:919
Droms RJ, Rork JF, McLean R et al (2017) Menkes disease mimicking child abuse. Pediatr Dermatol 34:e132–e134
Martinelli D, Travaglini L, Drouin CA et al (2013) MEDNIK syndrome: a novel defect of copper metabolism treatable by zinc acetate therapy. Brain 136:872–881
Goodman SI, Markey SP, Moe PG et al (1975) Glutaric aciduria; a "new" disorder of amino acid metabolism. Biochem Med 12:12–21
Larson A, Goodman S (2019) Glutaric acidemia type 1. GeneReviews. https://www.ncbi.nlm.nih.gov/books/NBK546575. Accessed 27 May 2020
Tortorelli S, Hahn SH, Cowan TM et al (2005) The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric acidemia type I. Mol Genet Metab 84:137–143
Vester M, Bilo R, Karst W et al (2015) Subdural hematomas: glutaric aciduria type 1 or abusive head trauma? A systematic review. Forensic Sci Med Pathol 11:405–415
Byers PH (1999) Vascular Ehlers–Danlos syndrome. GeneReviews. https://www.ncbi.nlm.nih.gov/books/NBK1494. Accessed 26 April 2020
Pepin M, Schwarze U, Superti-Furga A, Byers PH (2000) Clinical and genetic features of Ehlers–Danlos syndrome type IV, the vascular type. N Engl J Med 342:673–680
Pepin MG, Schwarze U, Rice KM et al (2014) Survival is affected by mutation type and molecular mechanism in vascular Ehlers–Danlos syndrome (EDS type IV). Genet Med 16:881–888
Zilocchi M, Macedo TA, Oderich GS et al (2007) Vascular Ehlers–Danlos syndrome: imaging findings. AJR Am J Roentgenol 189:712–719
Castori M, Voermans NC (2014) Neurological manifestations of Ehlers–Danlos syndrome(s): a review. Iran J Neurol 13:190–208
Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424
Eccles D, Mitchell G, Monteiro A et al (2015) BRCA1 and BRCA2 genetic testing — pitfalls and recommendations for managing variants of uncertain clinical significance. Ann Oncol 10:2057–2065
Paul S, Narang S (2017) Expert witness participation in civil and criminal proceedings. Pediatrics 139:3
Acknowledgments
We acknowledge Marshall Summar, MD, Jamie Fraser, MD, Lori Frasier, MD, Debra Regier, MD, Allison Jackson, MD, Gilbert Vezina, MD, Adrianne Artis, MD, Brad T. Tinkle, MD, PhD, and the patients and families whom we all serve.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shur, N.E., Summerlin, M.L., McIntosh, B.J. et al. Genetic causes of fractures and subdural hematomas: fact versus fiction. Pediatr Radiol 51, 1029–1043 (2021). https://doi.org/10.1007/s00247-020-04865-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-020-04865-0